Automating Gastroenterology Peer-to-Peer Scheduling for GI Practices

Klivira streamlines gastroenterology peer-to-peer scheduling, transforming a high-friction process into an automated workflow that reduces clinician burden and accelerates critical approvals.

For revenue cycle directors and prior authorization coordinators in gastroenterology, managing peer-to-peer (P2P) reviews for complex cases is a significant operational challenge. Denials for high-cost biologics, advanced imaging, and specialized procedures frequently necessitate P2P discussions, consuming valuable clinician time and delaying patient care. Klivira's platform automates key aspects of the P2P scheduling workflow, specifically tailored to the unique demands of GI.

The P2P Imperative in Gastroenterology Prior Authorization

Gastroenterology practices face a disproportionate volume of prior authorization denials that often escalate to peer-to-peer review. This is particularly true for chronic conditions requiring biologics like Humira, Stelara, Skyrizi, and Entyvio for Crohn's disease and ulcerative colitis, where step therapy and biosimilar substitution policies frequently trigger initial denials. Additionally, advanced imaging (MRCP, MR enterography) and specific endoscopic procedures (capsule endoscopy, ERCP, EUS) are common PA triggers that may lead to P2P discussions if medical necessity is contested by payers.

Common GI PA Denials Requiring Peer-to-Peer Intervention

Step therapy non-compliance for IBD biologics (e.g., requiring 5-ASA or TNF inhibitor trial first).
Payer-mandated biosimilar substitution when a brand TNF inhibitor is prescribed.
Insufficient documentation of disease severity (e.g., missing Mayo score, CDAI) for biologic initiation.
Gaps in pre-biologic screening documentation (e.g., TB, hepatitis).
Clinical necessity disagreement for advanced imaging or capsule endoscopy indications.
Misclassification of treatment-naive vs. treatment-experienced status for Hep C DAAs or IBD biologics.

Klivira's Automated Gastroenterology Peer-to-Peer Scheduling Workflow

Klivira's platform integrates directly with your EMR and payer portals to automate the complex process of scheduling peer-to-peer reviews. Our denial-router identifies P2P-eligible cases, such as those related to clinical necessity disagreements or off-label indications for GI specialty drugs. This intelligent triage ensures that appropriate cases are immediately routed into the automated scheduling workflow, minimizing delays and reducing manual intervention.

Key Automation Steps for GI Peer Reviews

**Payer-Side Window Discovery:** Klivira ingests payer-published P2P availability or initiates requests via payer portals/secure messaging.
**Clinician Calendar Integration:** Reads gastroenterologist's availability via FHIR Appointment resources or integrated calendar systems (Outlook, Google Calendar).
**Optimal Window Proposal:** Proposes the earliest mutually available time slot to both the payer and the ordering clinician.
**Pre-Call Packet Assembly:** Automatically pulls relevant clinical notes, prior-line therapy, lab/imaging results, and ACG/AGA/AASLD guideline-aligned documentation via FHIR for the clinician.
**Automated Reminders:** Sends timely reminders to both the clinician and coordinator with the assembled clinical packet.
**Outcome Capture & EMR Write-back:** Facilitates structured outcome capture post-call, writing back to the EMR as FHIR DocumentReference and Communication resources.

Strategic Advantages for Gastroenterology Practices

By automating gastroenterology peer-to-peer scheduling, Klivira significantly reduces the administrative burden on PA coordinators and frees up valuable clinician time. This automation minimizes the risk of missed P2P windows, ensures clinicians are fully prepared with comprehensive documentation, and accelerates the resolution of denials. The result is improved patient access to critical GI treatments and procedures, enhanced revenue cycle efficiency, and reduced clinician burnout, as cited in AMA surveys regarding PA-related activities.

Frequently asked questions

How does Klivira handle step therapy denials for GI biologics in P2P scheduling?

Klivira's platform is designed with ACG/AGA-guideline-aware logic for IBD biologic sequencing. When a step therapy denial triggers a P2P, Klivira assembles documentation demonstrating prior conventional therapy trials or specific clinical reasons for bypassing steps, preparing the gastroenterologist for the discussion with the payer's medical director.

What EMR data does Klivira use for GI P2P documentation?

Klivira leverages FHIR-based integration to pull critical EMR data for GI P2P documentation. This includes medication history for treatment-status classification (e.g., treatment-naive vs. experienced for IBD biologics or Hep C DAAs), disease severity scores (Mayo score, CDAI), lab results (TB/hepatitis screening), imaging reports, and clinical notes relevant to the medical necessity of procedures or drugs.

Can Klivira integrate with my gastroenterologist's calendar for P2P scheduling?

Yes, Klivira supports clinician calendar integration via FHIR Appointment resources where available, or through customer-configured integrations with common calendar systems like Outlook and Google Calendar. This allows Klivira to automatically identify and propose mutually available time slots for P2P calls, eliminating manual reconciliation.

Does Klivira track the outcomes of gastroenterology peer reviews?

Absolutely. Post-call, Klivira provides a structured form for clinicians to capture the P2P outcome (approval, modification, upheld denial). This outcome is then routed back to the EMR as FHIR DocumentReference and Communication writes, and triggers downstream workflows such as approval write-back or appeal escalation, providing full transparency and auditability.

How does Klivira help with re-authorization for chronic GI conditions?

For chronic GI conditions like IBD requiring periodic re-authorization of biologics, Klivira maintains a periodic re-authorization workflow. Should a re-authorization be denied and require a P2P, the system will initiate the automated scheduling and documentation process, ensuring continuous treatment access and reducing the administrative load associated with ongoing PA burdens.